Sharma, V., Bagrodia, V., & Kulshreshtra, A. (2024). Enhancing hemophilia A management: emicizumab as a cost-effective adjunct to standard therapy for inhibitor patients. International Journal of Basic & Clinical Pharmacology, 13(3), 395–397. https://doi.org/10.18203/2319-2003.ijbcp20241000